Research has shown that in patients with metabolic syndrome, primarily exhibiting insulin resistance, increased circulating insulin levels may lead to enhanced synthesis and uptake of fatty acids by hepatic lipogenic cells, exacerbating triglyceride accumulation in the liver (24, 25). The gene discussed is INS; the disease is metabolic syndrome.